Biote (BTMD) Liabilities and Shareholders Equity (2020 - 2026)

Biote has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $89.0 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 27.84% year-over-year to $89.0 million; the trailing twelve-month figure through Mar 2026 stood at $412.8 million (down 6.17% YoY), and the FY2025 full-year result was $107.6 million, down 12.06% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $89.0 million, down from $107.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $317.9 million in Q1 2022, with the low at $89.0 million in Q1 2026.
• Average Liabilities and Shareholders Equity over 5 years is $131.2 million, with a median of $115.3 million recorded in 2022.
• Peak annual rise in Liabilities and Shareholders Equity reached 105.49% in 2022, while the deepest fall reached 65.57% in 2022.
• Tracing BTMD's Liabilities and Shareholders Equity over 5 years: stood at $111.6 million in 2022, then jumped by 39.1% to $155.3 million in 2023, then slipped by 21.2% to $122.4 million in 2024, then dropped by 12.06% to $107.6 million in 2025, then decreased by 17.27% to $89.0 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $89.0 million (Q1 2026), $107.6 million (Q4 2025), and $111.3 million (Q3 2025), per Business Quant data.

Peer Comparison